Development
BioXcel Therapeutics, Inc.
BTAI
$1.84
$0.3120.26%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 89.96M | 127.55M | 165.52M | 193.73M | 232.31M |
| Total Receivables | 735.00K | 431.00K | 283.00K | 248.00K | -- |
| Inventory | 2.02M | 1.93M | 1.95M | 1.99M | 1.41M |
| Prepaid Expenses | 3.85M | 3.70M | 4.51M | 3.07M | 5.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.17M | 4.64M | 5.01M | 3.84M | 2.43M |
| Total Current Assets | 98.74M | 138.24M | 177.27M | 202.87M | 241.66M |
|
|
|||||
| Total Current Assets | 98.74M | 138.24M | 177.27M | 202.87M | 241.66M |
| Net Property, Plant & Equipment | 1.62M | 1.78M | 1.91M | 2.06M | 2.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 87.00K | 87.00K | 925.00K | 925.00K | 925.00K |
| Total Assets | 100.45M | 140.10M | 180.10M | 205.85M | 244.82M |
|
|
|||||
| Total Accounts Payable | 10.67M | 11.20M | 7.74M | 10.23M | 5.87M |
| Total Accrued Expenses | 27.67M | 22.94M | 20.21M | 22.18M | 16.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 339.00K | 332.00K | 325.00K | 319.00K | 312.00K |
| Total Finance Division Other Current Liabilities | 735.00K | 265.00K | 478.00K | 167.00K | 609.00K |
| Total Other Current Liabilities | 735.00K | 265.00K | 478.00K | 167.00K | 609.00K |
| Total Current Liabilities | 39.41M | 34.74M | 28.76M | 32.90M | 23.38M |
|
|
|||||
| Total Current Liabilities | 39.41M | 34.74M | 28.76M | 32.90M | 23.38M |
| Long-Term Debt | 99.09M | 96.85M | 95.06M | 93.05M | 91.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 529.00K | 617.00K | 703.00K | 786.00K | 868.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.03M | 2.03M | 2.57M | 2.34M | 1.89M |
| Total Liabilities | 141.06M | 134.23M | 127.10M | 129.08M | 117.83M |
|
|
|||||
| Common Stock & APIC | 527.73M | 523.72M | 517.35M | 488.32M | 483.72M |
| Retained Earnings | -568.34M | -517.86M | -464.34M | -411.55M | -356.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -40.61M | 5.86M | 53.01M | 76.78M | 126.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -40.61M | 5.86M | 53.01M | 76.78M | 126.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -40.61M | 5.86M | 53.01M | 76.78M | 126.99M |
|
|
|||||